UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

Annals of oncology, 2018-10, Vol.29, p.viii90-viii90

2018

Volltextzugriff (PDF)

Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

Annals of oncology, 2018-10, Vol.29, p.viii64-viii64

2018

Volltextzugriff (PDF)

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?

Cancer treatment reviews, 2022-05, Vol.106, p.102392-102392, Article 102392

2022

Volltextzugriff (PDF)

Why Has US Policy Uncertainty Risen Since 1960?

The American economic review, 2014-05, Vol.104 (5), p.56-60

2014

Volltextzugriff (PDF)

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD3-03-PD3-03

2019

Volltextzugriff (PDF)

Abstract P6-18-02: Primary and secondary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P6-P6-18-02

2019

Volltextzugriff (PDF)

Abstract P2-09-04: Association of intrinsic subtype and immune genes with pathological complete response in the OPTIHER-HEART phase II clinical trial following neoadjuvant trastuzumab/pertuzumab-based chemotherapy in HER2-positive breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-09-04

2018

Volltextzugriff (PDF)

Abstract P5-11-04: Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P5-P5-11-04

2019

Volltextzugriff (PDF)

284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

VENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial

Annals of oncology, 2017-09, Vol.28, p.v66-v66

2017

Volltextzugriff (PDF)

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy for metastatic TNBC: First results of the safety run-in phase of the TILS001 clinical trial

ESMO open, 2024-05, Vol.9, p.103221, Article 103221

2024

Volltextzugriff (PDF)

AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain

Annals of oncology, 2017-09, Vol.28, p.v104-v105

2017

Volltextzugriff (PDF)

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors

Industrial & labor relations review, 1995-04, Vol.48 (3), p.486

1995

Volltextzugriff (PDF)

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors

Industrial & labor relations review, 1995-04, Vol.48 (3), p.486-504

1995

Volltextzugriff (PDF)

JOURNALISM AS LABOR POWER

The Fourth Enemy, 2012, p.116

Cane, James

2012

Volltextzugriff (PDF)

THE FOURTH ENEMY

The Fourth Enemy, 2012, p.206

Cane, James

2012

Volltextzugriff (PDF)

JOURNALISM AND POWER IN THE IMPOSSIBLE REPUBLIC

The Fourth Enemy, 2012, p.58

Cane, James

2012

Volltextzugriff (PDF)

THE TRIUMPH OF SILENCE

The Fourth Enemy, 2012, p.91

Cane, James

2012

Volltextzugriff (PDF)

INTRODUCTION: FROM FOURTH ESTATE TO FOURTH ENEMY

The Fourth Enemy, 2012, p.1

Cane, James

2012

Volltextzugriff (PDF)

THE DIE IS CAST

The Fourth Enemy, 2012, p.177

Cane, James

2012

Volltextzugriff (PDF)

THE FOURTH ESTATE

The Fourth Enemy, 2012, p.25

Cane, James

2012

Volltextzugriff (PDF)

SCENES FROM THE PRESS WARS

The Fourth Enemy, 2012, p.143

Cane, James

2012

Volltextzugriff (PDF)

CONCLUSION: JOURNALISM AND POWER IN THE NEW ARGENTINA

The Fourth Enemy, 2012, p.228

Cane, James

2012

Volltextzugriff (PDF)

Following in her footsteps? Faculty gender composition and w

Industrial & labor relations review, 1995-04, Vol.48 (3), p.486

1995

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Primary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

Oncolytic viruses: A new immunotherapeutic approach for breast cancer treatment?

Why Has US Policy Uncertainty Risen Since 1960?

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

Abstract P6-18-02: Primary and secondary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

Abstract P2-09-04: Association of intrinsic subtype and immune genes with pathological complete response in the OPTIHER-HEART phase II clinical trial following neoadjuvant trastuzumab/pertuzumab-based chemotherapy in HER2-positive breast cancer

Abstract P5-11-04: Anti-proliferative effect of oral metronomic vinorelbine (mVNB) in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): A randomized, three-arm, window-of-opportunity study

284OPrimary results of the first nationwide molecular screening program in Spain for patients with advanced breast cancer (AGATA SOLTI-1301 study)

199PAnti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

VENTANA (SOLTI-1501): Antiproliferative effect of the addition of oral metronomic vinorelbine to endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial

199P Adoptive PD1+ tumor-infiltrating lymphocyte therapy for metastatic TNBC: First results of the safety run-in phase of the TILS001 clinical trial

AGATA molecular screening program: Implementing precision medicine in patients with advanced breast cancer in Spain

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors

Following in Her Footsteps? Faculty Gender Composition and Women's Choices of College Majors

JOURNALISM AS LABOR POWER

THE FOURTH ENEMY

JOURNALISM AND POWER IN THE IMPOSSIBLE REPUBLIC

THE TRIUMPH OF SILENCE

INTRODUCTION: FROM FOURTH ESTATE TO FOURTH ENEMY

THE DIE IS CAST

THE FOURTH ESTATE

SCENES FROM THE PRESS WARS

CONCLUSION: JOURNALISM AND POWER IN THE NEW ARGENTINA

Following in her footsteps? Faculty gender composition and w

Suchergebnisse filtern